© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Pharmaceutical progress has always drawn my attention, and Zileuton stands out as a product of persistent research into inflammation. Scientists working through the late 1980s and early 1990s faced asthma’s stubborn biology. They didn’t settle for bronchodilators and steroids; curiosity drove them to track the leukotriene pathway, which plays a huge role in inflammation and constriction in the airways. Zileuton came out of this hunt as the first inhibitor that targeted 5-lipoxygenase, the enzyme that begins the leukotriene synthesis cascade. This pathway, mapped out by experts from institutions and industry, led to Zileuton’s approval by the FDA in 1996. It entered the field as an alternative for asthma patients who needed something beyond antihistamines and corticosteroids. Since then, Zileuton has become a reference point for anti-inflammatory research, not only for asthma but for any condition where leukotrienes stir up trouble.
Every medication brings a backstory built from years of tweaking and trials. Zileuton’s main job lies in asthma control, especially where symptoms resist gentler drugs. Marketed as Zyflo, its role centers on stopping certain inflammatory signals by blocking the key enzyme in leukotriene synthesis. It finds use in both regular clinical treatment and specialized hospital care, especially where patients face persistent wheezing and inflammation. For manufacturers, bringing Zileuton to market requires not only meeting tight quality controls but also educating doctors on proper dosing; it's a medication that works best in persistently inflamed lungs, rather than as a quick fix for acute attacks.
Zileuton’s molecules don’t jump out with wild complexity, but the details still matter. The drug often appears as an off-white powder, notable for its poor solubility in water—a chemistry quirk that shapes how it’s formulated for use. Its molecular formula is C11H12N2O2S, built from a benzothiophene structure with nitrogen and oxygen stitched in for targeted reactivity. This arrangement gives Zileuton a molecular weight around 236.29 g/mol. The drug’s stability under light and regular room conditions allows for manageable storage, but its water insolubility pushes formulators to rely on tablets rather than liquid forms. Technicians pay close attention to its crystalline form during manufacturing because small changes here can tweak how it gets absorbed in the body.
Every bottle of Zileuton comes with technical specs shaped by its route of delivery and the populations it serves. Standard formulation carries 600 mg per tablet, which lets clinicians dose accurately to reach therapeutic levels while minimizing toxicity. Labeling covers batch number, expiration date, storage instructions (keep out of excessive heat and humidity), manufacturer, and dosing directions. The U.S. Pharmacopeia sets strict limits on permissible impurities, often less than 1%. Packaging also warns about liver toxicity, which isn’t a trivial risk; this makes liver enzyme monitoring standard practice. Patients are often reminded that the drug isn’t designed for acute asthma attacks and requires regular use to deliver benefits.
Zileuton comes to life through organic synthesis, usually in specialized facilities that keep a close watch on purity every step of the way. Chemists use a multi-step process that starts with benzothiophene-2-acetic acid, which undergoes amide coupling and several protection-deprotection rounds to graft the needed side chains. Creating its structure takes strong acid or base catalysis for certain steps, calling for good ventilation and chemical know-how. After synthesis, the crude product passes through several purification cycles, often including recrystallization and chromatography, to whittle down impurities. Yield matters in these operations: manufacturers balance high output with the absolute need for clean product free from process chemicals.
Chemically, Zileuton resists a lot of breakdown, which is a boon for medicine but a hurdle for researchers hunting new derivatives. When exposed to strong acids or bases, it can hydrolyze at certain bonds, breaking down to its constituent acids and amines. Researchers have explored modifications at the amide and benzothiophene groups, aiming to build drugs with better absorption or longer action. Some work has focused on attaching water-soluble handles—adding polar groups—in a drive to develop intravenous formulations. Other teams explore its metabolism in the liver, tracking how cytochrome enzymes oxidize parts of the molecule and sometimes create new active ingredients. Each chemical tweak has to respect the core structure responsible for 5-lipoxygenase inhibition, or risk losing the drug’s original purpose.
Walk into a pharmacy, and you’ll spot Zileuton under names like Zyflo or Zyflo CR. In chemical databases, it pops up as N-(1-benzothiophen-2-ylethyl)-N-hydroxyurea, a name that unpacks its backbone piece by piece. Researchers might also call it CL 231791 or by its registry numbers in standard chemical catalogs. These aliases help researchers cross-check clinical data, spot patents, and find relevant toxicology studies scattered across international literature.
Zileuton has pulled its weight in asthma care, but its safety profile comes with cautions that every practitioner learns quick. The medication’s main risk comes from liver function—enzymes can spike in some patients, a side effect that can slip by unless monitored with regular blood work. Healthcare workers keep an eye on hypersensitivity, since rare allergic reactions have cropped up. In the manufacturing plant, operators work inside negative-pressure rooms, wearing gloves and using local exhaust to limit airborne powder. Disposing of excess or outdated Zileuton follows strict hazardous pharmaceutical waste standards due to environmental and human health concerns. Distributors carry out periodic audits, while pharmacists often counsel patients about food-drug and drug-drug interactions: Zileuton can crank up levels of other drugs by slowing their breakdown in the liver.
Doctors turn to Zileuton most for moderate to severe asthma, particularly where standard inhalers and theophylline leave patients struggling for breath. The drug’s influence on leukotriene synthesis gives it a special place in cases marked by persistent airway inflammation. Some research teams have tested its value in treating exercise-induced asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD), though these uses haven’t become standard care. Its ability to ease inflammation has inspired pilot studies in fields as far-flung as rheumatoid arthritis and atopic dermatitis, given the overlap in the body’s inflammatory circuits. Beyond individual treatment, Zileuton’s development pushed labs worldwide to re-examine asthma’s root causes, helping shift the conversation from mere symptom control to targeted immunological intervention.
Decades of lab work and clinical trials have sharpened Zileuton’s impact, but the story doesn’t freeze there. Research teams chase next-generation 5-lipoxygenase inhibitors, measuring newer molecules against Zileuton as a standard yardstick. Thanks to advances in genomic and proteomic profiling, researchers now sort patients by molecular asthma subtypes, looking for those most likely to benefit. Ongoing trials compare once- and twice-daily versions, aiming for easier regimens. Another area that keeps researchers busy involves combinatory therapy: partnering Zileuton with inhaled corticosteroids and long-acting beta-agonists to explore added benefits. The scientific literature continues to fill with case reports from allergists and pulmonologists who test its potential in unusual or drug-resistant conditions.
Safety claims in medicine always draw scrutiny, and Zileuton’s story follows that pattern. Early clinical trials picked up on dose-dependent liver toxicity; a proportion of patients developed raised transaminases, sometimes high enough to halt therapy. This discovery shaped stringent prescribing and monitoring guidelines, with education emphasizing risk to those with pre-existing liver conditions or those taking other hepatotoxic drugs like acetaminophen. Researchers have measured Zileuton’s safety profile in animal models, testing acute, subchronic, and long-term exposure. These efforts highlighted potential developmental toxicity at large doses, though real-world dosing keeps a wide margin below those thresholds. Vigilant post-market surveillance captures any rare adverse reactions, feeding back into treatment guidelines.
People living with asthma still face rough patches, and medications like Zileuton offer an option that suits some of those hard-to-treat situations. As science uncovers the nuanced subtypes of asthma and inflammation, the door remains open for modifications or entirely new compounds that extend Zileuton’s legacy. Drug delivery researchers work on formulations with better absorption or sustained release. Interest in the broader effects of leukotrienes—within the nervous system, in the cardiovascular field—could spark new uses for Zileuton or its successors. If advances can cut toxicity without losing its unique power, Zileuton and similar drugs can sit alongside, not replace, today’s standard treatments. Looking back at the journey from early synthesis to creditable asthma care, Zileuton proves how one compound, when rooted in biochemistry, can nudge medicine in new and lasting directions.
Asthma can catch you off guard. For a lot of people, coughing, shortness of breath, and chest tightness are just part of daily life. In many cases, inhalers help. But some folks still struggle despite trying the regular treatments. Here’s where zileuton comes into play. As someone who has watched loved ones navigate asthma for years, I’ve seen how not every medication fits every person. Zileuton offers a different approach, especially for those whose asthma won’t quit even with regular care.
Instead of targeting symptoms right when they appear, zileuton gets ahead of the process. It blocks an enzyme called 5-lipoxygenase. This enzyme makes leukotrienes, which are chemicals in the body that tighten airway muscles and spark inflammation. In simple terms, zileuton prevents some of the root causes of asthma flare-ups. Clinical studies back this up. A review in the Journal of Asthma highlights that people taking zileuton often see fewer nighttime attacks and grab their rescue inhalers less.
Most asthma medicines fall into two groups. There are quick-acting inhalers for sudden relief. Then there are long-term controllers, like steroids and leukotriene receptor antagonists (montelukast, for example). Zileuton stands out by addressing leukotriene production itself, not just the symptoms these molecules cause. Doctors often reach for zileuton when standard controllers aren’t enough or a person can’t take inhaled steroids. Certain types of asthma, including those triggered by allergies or exercise, can be especially tough to manage. Experience shows that people in these situations find zileuton a welcome option.
Zileuton isn’t a miracle drug, and it’s not for everybody. It impacts the liver, so regular blood tests help spot problems early. People with liver disease must be cautious. Some drugs interact with zileuton, including common pain relievers and blood thinners. Being open with your doctor about everything you take really matters here. Over the years, I’ve seen patients avoid issues by keeping their care team updated.
Asthma varies from person to person, and so should the strategy for managing it. Zileuton brings another tool when other options either fall short or cause too many side effects. The U.S. Food and Drug Administration approved zileuton for folks over 12 who need help controlling chronic asthma. For families struggling to manage daily symptoms, having more than one way to tackle inflammation offers hope.
Looking at the bigger picture, better asthma education makes a world of difference. Doctors, pharmacists, and patients working together spot risks early on and adjust treatment. Research keeps producing new asthma medicines, but real-life stories show nothing replaces honest communication between health professionals and families. When someone isn’t responding to inhalers or steroids, zileuton springs up as an option worth considering. What matters most is a plan that fits each person’s daily reality, giving them the chance to breathe just a bit easier.
Breathing problems can sneak up on ordinary days. Some notice the wheeze, the cough, or the chest tightness more after a run or after cleaning a dusty room. For anyone living with asthma, those reminders aren’t minor. Zileuton, a prescription medication, steps into this story with a distinct goal—helping folks with asthma get a handle on their airways.
Zileuton acts by blocking an enzyme called 5-lipoxygenase. This enzyme helps produce leukotrienes, which are substances that trigger inflammation, tighten airway muscles, and bring about extra mucus. When we think about an asthma flare-up, the culprits often trace back to these leukotrienes. Blocking their production means the chain reaction can’t get started as easily. For someone who has felt the loss of control from an asthma attack, this blockade matters.
Many asthma medications focus on relaxing airway muscles after symptoms flare, but zileuton goes after the starting process. By stopping the body from making certain chemical messengers in the first place, zileuton doesn’t just patch over symptoms. Instead, it aims to prevent that whole cascade of swelling and narrowing in the breathing tubes.
This isn’t just a laboratory theory. The National Institutes of Health, along with asthma specialists, highlight how patients taking zileuton experience fewer nighttime symptoms and stronger lung function scores. Not everyone gets the same results, but for many, daily life changes. Routine walks, school activities, or playing with kids come with less worry over a surprise attack.
Zileuton won’t erase asthma from someone’s life. It does add another option to the toolbox, especially if inhalers and steroids alone aren’t enough. Doctors usually reserve it for those with persistent symptoms despite the usual treatments. The plan involves taking tablets regularly, not just “as needed.” Consistency makes the difference because zileuton fights a chronic process, not just the loud flares.
Kids aged twelve and up can also use zileuton, widening its reach. That’s important because teenagers struggle with asthma symptoms as they juggle school and sports. For parents with asthmatic teens, the extra option sometimes helps restore a bit of normalcy.
Every medication comes with downsides. With zileuton, the liver process deserves attention. Some people see liver enzymes climb while on this drug, which means regular blood checks matter. For anyone with a history of liver trouble, the doctor and patient both need to weigh the risks together.
Mixing zileuton with certain other drugs changes how the body breaks things down, too. If you already use blood thinners, the pharmacy team should double-check your other prescriptions. That’s a practical point that families and doctors navigate together.
Asthma hasn’t gotten easier over the years. Pollution, seasonal allergies, and rapid weather shifts keep making things harder for those who struggle to breathe. For chronic asthma, broadening the medication options means fewer trips to the emergency room. Oral drugs such as zileuton support that goal, especially for anyone who finds inhalers alone don’t solve the problem.
Asthma control rarely works as a one-size-fits-all plan. The best care comes from steady attention to symptoms, honest conversations with doctors, and making room for new research-backed options. Zileuton doesn’t replace other asthma treatments, but it adds a layer of prevention that some people find essential.
Zileuton, a medication used for managing asthma, blocks a specific enzyme in the body that helps create substances called leukotrienes. These chemicals can stir up inflammation and tighten airways, making it hard to breathe. For some people with asthma, Zileuton has offered much-needed relief. Still, any drug tweaking the body can bring baggage, and patients should know what to watch out for.
Many doctors keep a close eye on the liver whenever someone starts Zileuton. Elevated liver enzymes show up frequently, according to the U.S. National Library of Medicine. As someone who’s dealt with managing medications for chronic illness, I’ve learned that even small shifts can signal bigger issues ahead. Some patients may feel fine, never suspecting anything until a routine blood test lights up. That’s why physicians recommend regular bloodwork when using Zileuton, especially in the first few months. Signs of liver trouble like yellowed skin, dark urine, or sharp pain in the upper stomach demand a quick phone call to the clinic.
No one likes feeling queasy, and Zileuton sometimes brings mild nausea, stomach cramps, or even vomiting. I’ve noticed that people tend to downplay these effects, but unchecked queasiness can discourage folks from sticking with treatment. Headaches pop up, as well. Reports say these symptoms affect up to one in ten people. Eating before taking the medicine sometimes helps settle the stomach, though each patient finds their own groove.
The FDA has flagged some rare, but real, behavioral changes tied to Zileuton. Sleeplessness, wild dreams, or feeling unusually anxious have all been recorded. In a world where mental health still gets overlooked, even small changes can snowball for people who struggle with anxiety or mood swings. Direct conversations—doctor to patient—matter most here. Reporting sleep problems or mood shifts right away often leads to quick adjustments or a switch to another medication.
Asthma brings frustration, lost sleep, and worry. A new drug can seem daunting. Patients and healthcare professionals walk a delicate line, trading side effects for fewer asthma attacks and better lung health. It helps to stay informed and to bring up every concern, no matter how small it feels. The FDA and other trusted sources update risk information as new cases surface.
It’s a two-way street: doctors need honest feedback, and patients deserve respect for their lived experiences. Regular appointments, honest conversation, and awareness of red-flag symptoms can keep problems small and manageable. Medications aren't just chemicals—they’re part of life, with all the ups and downs that come with it. If anyone notices yellowing eyes, stomach pain, dark urine, or new mood changes while taking Zileuton, dropping a quick message to the healthcare provider makes all the difference.
A lot of folks with asthma look for that one crucial thing—a way to keep symptoms from crashing in and stealing the breath away. For many who’ve dealt with wheezing after mowing the lawn or running to catch a bus, daily control means everything. Zileuton entered the scene to fill that need, not by replacing quick-relief inhalers, but by giving long-term support. This medicine blocks leukotrienes, those sneaky chemicals inside the body that fire up swelling and tighten airways.
Doctors lay out a clear plan for zileuton. Pill form, taken four times a day. That schedule isn’t just for show. Zileuton steps in and works across the clock, so skipped doses can let inflammation slip through the cracks. Sticking to breakfast, lunch, dinner, and bedtime keeps blood levels steady—this isn’t up for debate based on convenience. For adults and youngsters over 12, it’s usually 600 milligrams at each of those four times. Having tried my hand at those routines for other meds, devices like smartphone alarms can help. Keep that pill bottle where it’s hard to forget. Doubling up next meal doesn’t fix a missed dose, either; doing so risks piling on side effects.
Taking zileuton with food isn’t just a throwaway suggestion. Some people feel queasy or get upset stomachs if they swallow it on an empty gut. A glass of water and a meal can help the body accept that medicine. This also gives routines a structure—medicine and breakfast go together, so it’s less likely you’ll forget.
Liver health stands front and center here. Zileuton, the same as certain other medications, asks the liver to do some real work. Doctors ask for blood tests before starting it and then every few months. That might sound demanding. But I’d take a poked vein and a little band-aid over letting problems grow in secret. Regular check-ins mean you can spot issues early, long before symptoms start to show up. If blood tests flag rising enzymes, it’s time to rethink the plan. No one deserves nasty surprises like jaundice or sudden fatigue from unchecked liver strain.
Zileuton doesn’t fly solo. When mixed with other medications—especially warfarin, theophylline, or propranolol—levels in the body can shift in risky ways. It always pays to speak up about everything you’re taking, prescription or not. Grapefruit or herbal supplements sometimes toss unexpected wrenches into the works. Pharmacists and doctors can spot these pitfalls because they see these combinations again and again. No one at the pharmacy should judge. They’re there to help connect the dots and protect your health.
Asthma management feels overwhelming, especially for people juggling work, school, or caring for family. Community support and good conversations with providers help lower the pressure. Written reminders or blister packs can be more than just handy; they take willpower out of the equation. In my experience, trusted routines work better than perfect willpower. Everyone deserves to breathe easier—sometimes it just takes the right tools and a medicine cabinet calendar.
Each prescription medicine has its quirks, but zileuton comes with a special list of things to watch for. People use zileuton to manage asthma by blocking an enzyme involved in asthma attacks. Sounds straightforward, but the real story unfolds once it gets inside the body and starts mingling with other medicines.
Lots of folks on zileuton are also taking something else. Often it’s because asthma doesn’t show up alone—there’s high cholesterol, blood pressure, pain, or even depression that tag along. Zileuton, though, is processed in the liver using cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP3A4). That basically turns the liver into a busy intersection at rush hour.
Adding anything that uses those same enzymes can turn a simple drive into a pileup. The heavy hitters? Warfarin (a blood thinner), theophylline (breathing help), and propranolol (blood pressure support) often get slowed down or speeded up by zileuton. Levels of these drugs can rise higher than planned, which risks nasty side effects—uncontrollable bleeding, shaky hands, an irregular heartbeat, to name a few.
Acetaminophen, aspirin, and even caffeine sneak onto the list too. These aren’t rare pills. Anyone hitting a morning coffee and painkiller for a headache has a dog in this fight. Mixing them with zileuton can make side effects stronger or leave drugs lingering too long.
Taking medicines that work in the liver means keeping a sharp eye on liver health. Zileuton on its own can bump up liver enzyme levels. Adding alcohol, or certain antibiotics, means asking the liver to do double duty. The stress from that combination can tip the liver into trouble. Blood tests can catch problems early, but the best approach is to notice things like yellow skin, dark urine, or stomach pain and get checked out right away.
It’s tempting to see each prescription as its own thing. But doctors need the full picture to keep people out of trouble. Patients forget, or maybe don’t realize, that even herbal supplements or over-the-counter pills count. Bringing a list of everything being taken—vitamins, herbal teas, pain relievers—makes a real difference. A simple family practice visit can turn into a life saver with the right information on the table.
Hospitals, clinics, and pharmacists benefit from electronic records that flag risky combinations. Not every system catches every interaction, especially with newer drugs or herbal remedies. That’s why trained professionals who ask the right questions matter.
Managing asthma is tough enough without surprise setbacks caused by a new prescription or a forgotten supplement. A few minutes spent looking at the whole medication list or catching up on recent lab results can keep everything on track.
Today, there’s a push for doctors and pharmacists to check liver tests often for people starting zileuton. For many, it feels like extra steps, but those steps ward off emergencies. Taking the time for regular check-ins, honest conversation, and a phone call before adding something new makes people safer—and keeps asthma where it belongs, under control.
| Names | |
| Preferred IUPAC name | N-(1-benzo[b]thien-2-ylethyl)-N-hydroxyurea |
| Other names |
Zyflo Zyflo CR |
| Pronunciation | /zaɪˈljuːtɒn/ |
| Identifiers | |
| CAS Number | 111406-87-2 |
| Beilstein Reference | Beilstein Reference: 6365629 |
| ChEBI | CHEBI:9606 |
| ChEMBL | CHEMBL1201 |
| ChemSpider | 9656 |
| DrugBank | DB00744 |
| ECHA InfoCard | 100.122.162 |
| EC Number | EC 1.13.11.34 |
| Gmelin Reference | 2593061 |
| KEGG | D08637 |
| MeSH | D015242 |
| PubChem CID | Machine-readable string: 57330 |
| RTECS number | OU8387000 |
| UNII | T9F3HK19Z5 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C11H12N2O2S |
| Molar mass | 236.3 g/mol |
| Appearance | White to off-white powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Insoluble |
| log P | 2.6 |
| Vapor pressure | 1.92E-14 mmHg |
| Acidity (pKa) | 4.32 |
| Basicity (pKb) | pKb = 7.13 |
| Magnetic susceptibility (χ) | -93.0e-6 cm³/mol |
| Refractive index (nD) | 1.638 |
| Dipole moment | 3.87 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 354.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -241.3 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -6615 kJ/mol |
| Pharmacology | |
| ATC code | R03DC01 |
| Hazards | |
| Main hazards | May cause liver injury; possible neuropsychiatric events; hypersensitivity reactions |
| GHS labelling | GHS labelling: Danger; H301, H311, H331, H373; P260, P264, P270, P271, P301+P310, P311, P405, P501 |
| Pictograms | liver, test-tube, prescription, pill |
| Signal word | Warning |
| Hazard statements | Hazard statements: H302, H315, H319, H335 |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | Zileuton has a flash point of 246.4 °C |
| Autoignition temperature | 270°C |
| Lethal dose or concentration | LD₅₀ (oral, rat): >2000 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Zileuton: "2200 mg/kg (rat, oral) |
| PEL (Permissible) | Not established |
| REL (Recommended) | Daxas (roflumilast) |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Arachidonic acid Montelukast Pranlukast Zafirlukast Leukotriene receptor antagonist |
